What COVID-19 variants are going around in April 2025?
Nebraska Medicine Omaha, NE - 14 Apr 2025What COVID-19 variants are going around in April 2025? ...
xbb variant
What COVID-19 variants are going around in April 2025? ...
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant
Nature - 13 Mar 2025Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant ...
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design
Duke University School of Medicine - 04 Sep 2024Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design ...
Genomic Surveillance for SARS-CoV-2 Variants: ...
Centers for Disease Control and Prevention | CDC (.gov) - 24 Oct 2024Genomic Surveillance for SARS-CoV-2 Variants: ... ...
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants
Frontiers - 16 Feb 2025XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants ...
COVID is surging again. Here’s the latest on new variants, updated vaccines, and masking
AAMC - 29 Aug 2024COVID is surging again. Here’s the latest on new variants, updated vaccines, and masking ...
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies | mBio
ASM Journals - 05 Mar 2025XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies | mBio ...
S. Korean health authorities reject baseless 'Omicron surge' warning
Fact Check AFP - 24 Jan 2025S. Korean health authorities reject baseless 'Omicron surge' warning ...
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform - eClinicalMedicine
The Lancet - 07 Dec 2024Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform - eClinicalMedicine ...
A health advisory about the COVID-19 xbb variant has not been issued by the CDC
KGW - 21 Aug 2024A health advisory about the COVID-19 xbb variant has not been issued by the CDC ...
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nature - 09 Jan 2025Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections ...
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells
Frontiers - 11 Mar 2025The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells ...
KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases
Centers for Disease Control and Prevention | CDC (.gov) - 19 Aug 2024KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases ...
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
Nature - 27 Jan 2025Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages ...
Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice
Frontiers - 01 Oct 2024Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice ...
Neutralizing antibody responses to three XBB protein vaccines in older adults
Nature - 03 Feb 2025Neutralizing antibody responses to three XBB protein vaccines in older adults ...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines
Nature - 20 Nov 2024Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines ...
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
Nature - 26 Feb 2025A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants ...
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials
Nature - 30 Dec 2024Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials ...